Efficacy and Safety of EXOSOME-MSC Therapy to Reduce Hyper-inflammation In Moderate COVID-19 Patients

Clinical trial NCT05216562 · UNKNOWN

Trial details

NCT number: NCT05216562
Sponsor: Dermama Bioteknologi Laboratorium
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

SARS-CoV2 Infection

Start date: 2021-07-01
Primary completion: 2022-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.